Financing
Financing Cash Flow
Gilead Sciences Financing Cash Flow decreased by 235.6% to -$4.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.7%, from -$3.43B to -$4.24B. Over 3 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a -4.4% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
Negative values often indicate a company is paying down debt or returning capital to shareholders, while positive values may indicate external financing.
Detailed definition
The net result of all cash inflows and outflows related to financing activities, including debt issuance, debt repayment...
Peer comparison
Highly dependent on the company's current capital structure and lifecycle stage compared to industry peers.
Metric ID:
net_cash_from_financingHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$931.00M | -$3.53B | -$1.94B | -$1.79B | -$1.00B | -$2.12B | -$1.55B | -$1.41B | -$1.10B | -$1.52B | -$1.10B | -$1.36B | -$2.95B | -$1.38B | -$3.43B | -$1.57B | -$1.49B | -$1.26B | -$4.24B |
| QoQ Change | — | -278.8% | +44.9% | +7.6% | +44.1% | -111.2% | +26.6% | +9.5% | +21.7% | -38.0% | +27.6% | -23.8% | -117.0% | +53.3% | -148.4% | +54.3% | +5.0% | +15.2% | -235.6% |
| YoY Change | — | — | — | — | -7.7% | +39.9% | +20.0% | +21.6% | -9.8% | +28.3% | +29.3% | +3.2% | -168.2% | +9.2% | -151.7% | +46.9% | -8.0% | — | -23.7% |
Range-$4.24B – -$931.00M
CAGR+40.1%
Avg YoY Growth-12.2%
Median YoY Growth+6.2%
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's financing cash flow?
- Gilead Sciences (GILD) reported financing cash flow of -$4.24B in Q1 2026.
- How has Gilead Sciences's financing cash flow changed year-over-year?
- Gilead Sciences's financing cash flow decreased by 23.7% year-over-year, from -$3.43B to -$4.24B.
- What is the long-term trend for Gilead Sciences's financing cash flow?
- Over 3 years (2021 to 2025), Gilead Sciences's financing cash flow has grown at a -4.4% compound annual growth rate (CAGR), from -$8.88B to -$7.75B.
- What does financing cash flow mean?
- The net cash flow generated or used by financing activities.